Literature DB >> 11992130

The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later.

Lucien Campeau1.   

Abstract

BACKGROUND: The Canadian Cardiovascular Society (CCS) grading of angina pectoris was described in the medical literature in 1976.
OBJECTIVES: To describe the origin of this grading, its worldwide acceptance, critiques, perceived limitations and alternative systems.
METHODS: The present author, who chaired the CCS ad hoc committee that developed this grading system in 1972, used documentation based on personal correspondence, and information from medline and international citation indexes searches.
RESULTS: The CCS committee's mandate was to standardize the definition of terms used in reporting studies of coronary artery disease and coronary artery bypass graft surgery. The committee defined a four-level system modelled on the New York Heart Association functional classification of patients with diseases of the heart, and the American Medical Association classes of organic heart diseases. Threshold activities that produced angina were detailed to assess reliably the severity of exertional angina by independent observers, and changes over time. The grading system has been cited over 650 times in the literature since its official publication in 1976. Although this grading system was found to be generally relevant and practical, several imperfections and potential limitations were reported, the most pertinent being the criterion "anginal syndrome may be present at rest" included in grade IV, which was found to be inappropriate and confusing. The prognostic significance of the grading system, despite the finding that this was not its primary goal, was also thought to be inadequate.
CONCLUSION: Although this grading system of the severity of effort angina has been accepted throughout the world over the past 30 years, a revision is desirable considering its potential imperfections and inconsistencies with present day management of ischemic heart disease.

Entities:  

Mesh:

Year:  2002        PMID: 11992130

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  32 in total

1.  Circulating platelet and neutrophil activation correlates with the clinical course of unstable angina.

Authors:  Satoshi Murasaki; Kagari Murasaki; Kenjiro Tanoue; Masatoshi Kawana; Nobuhisa Hagiwara; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2007-11-26       Impact factor: 2.037

2.  Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification.

Authors:  Padma Kaul; C David Naylor; Paul W Armstrong; Daniel B Mark; Pierre Theroux; Gilles R Dagenais
Journal:  Can J Cardiol       Date:  2009-07       Impact factor: 5.223

3.  Effect of Kuanxiong Aerosol () on Patients with Angina Pectoris: A Non-inferiority Multi-center Randomized Controlled Trial.

Authors:  Qiao-Ning Yang; Rui-Na Bai; Guo-Ju Dong; Chang-Jiang Ge; Jing-Min Zhou; Li Huang; Yan He; Jun Wang; Ai-Hua Ren; Zhan-Quan Huang; Guang-Li Zhu; Shu Lu; Shang-Quan Xiong; Shao-Xiang Xian; Zhi-Jun Zhu; Da-Zhuo Shi; Shu-Zheng Lu; Li-Zhi Li; Ke-Ji Chen
Journal:  Chin J Integr Med       Date:  2018-02-13       Impact factor: 1.978

4.  Two-year outcomes in patients with mild refractory angina treated with enhanced external counterpulsation.

Authors:  William E Lawson; John C K Hui; Elizabeth D Kennard; Sheryl F Kelsey; Andrew D Michaels; Ozlem Soran
Journal:  Clin Cardiol       Date:  2006-02       Impact factor: 2.882

Review 5.  The conundrum of detecting stable angina pectoris in the community setting.

Authors:  Mary Russell; Marie Williams; Esther May; Simon Stewart
Journal:  Nat Rev Cardiol       Date:  2009-12-22       Impact factor: 32.419

Review 6.  Antagonist molecules in the treatment of angina.

Authors:  Ashish K Gupta; David Winchester; Carl J Pepine
Journal:  Expert Opin Pharmacother       Date:  2013-09-18       Impact factor: 3.889

7.  Cost of illness for chronic stable angina patients enrolled in a self-management education trial.

Authors:  Michael H McGillion; Ruth Croxford; Judy Watt-Watson; Sandra Lefort; Bonnie Stevens; Peter Coyte
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

8.  Sex differences in independent factors associated with coronary artery disease.

Authors:  Alois Suessenbacher; Maria Wanitschek; Jakob Dörler; Sabrina Neururer; Matthias Frick; Otmar Pachinger; Hannes F W Alber
Journal:  Wien Klin Wochenschr       Date:  2014-09-13       Impact factor: 1.704

9.  Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients.

Authors:  Emilio Bouza; María Jesús Pérez Granda; Javier Hortal; José M Barrio; Emilia Cercenado; Patricia Muñoz
Journal:  Intensive Care Med       Date:  2013-06-28       Impact factor: 17.440

Review 10.  A review of health utilities using the EQ-5D in studies of cardiovascular disease.

Authors:  Matthew T D Dyer; Kimberley A Goldsmith; Linda S Sharples; Martin J Buxton
Journal:  Health Qual Life Outcomes       Date:  2010-01-28       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.